Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treg-depleted DLI for Relapsed Hematological Malignancies
NCT06180499Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2024
- Primary completion
- Nov 2028
- Modality
- Cell Therapies
01
Overview
A Phase 2 trial of Treg-depleted donor lymphocyte infusion in hematological malignancy, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
Treg-depleted donor lymphocyte infusion
03
Conditions
hematological malignancy
Beyond the preview
Go deeper on NCT06180499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06180499.